Interpace Biosciences (IDXG) Competitors

Interpace Biosciences (NASDAQ:IDXG) and Laboratory Co. of America (NYSE:LH) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends, valuation and community ranking.

Do analysts rate IDXG or LH?

Laboratory Co. of America has a consensus target price of $269.92, indicating a potential upside of 16.03%. Given Laboratory Co. of America's stronger consensus rating and higher possible upside, analysts clearly believe Laboratory Co. of America is more favorable than Interpace Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Interpace Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Laboratory Co. of America	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86

Does the media refer more to IDXG or LH?

In the previous week, Laboratory Co. of America had 19 more articles in the media than Interpace Biosciences. MarketBeat recorded 20 mentions for Laboratory Co. of America and 1 mentions for Interpace Biosciences. Laboratory Co. of America's average media sentiment score of 1.29 beat Interpace Biosciences' score of 0.00 indicating that Laboratory Co. of America is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Interpace Biosciences	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Laboratory Co. of America	15 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer IDXG or LH?

Laboratory Co. of America received 304 more outperform votes than Interpace Biosciences when rated by MarketBeat users. However, 72.83% of users gave Interpace Biosciences an outperform vote while only 63.96% of users gave Laboratory Co. of America an outperform vote.

Company	Underperform	Outperform
Interpace Biosciences	Outperform Votes 319 72.83%	Underperform Votes 119 27.17%
Laboratory Co. of America	Outperform Votes 623 63.96%	Underperform Votes 351 36.04%

Is IDXG or LH more profitable?

Interpace Biosciences has a net margin of 10.39% compared to Laboratory Co. of America's net margin of 5.73%. Laboratory Co. of America's return on equity of 15.29% beat Interpace Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Interpace Biosciences	10.39%	-8.09%	37.14%
Laboratory Co. of America	5.73%	15.29%	7.01%

Which has stronger valuation & earnings, IDXG or LH?

Laboratory Co. of America has higher revenue and earnings than Interpace Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Interpace Biosciences	$40.21M	0.10	$800K	N/A	N/A
Laboratory Co. of America	$13.01B	1.50	$746M	$8.82	26.38

Which has more volatility and risk, IDXG or LH?

Interpace Biosciences has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, Laboratory Co. of America has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of IDXG or LH?

5.7% of Interpace Biosciences shares are owned by institutional investors. Comparatively, 95.9% of Laboratory Co. of America shares are owned by institutional investors. 5.5% of Interpace Biosciences shares are owned by company insiders. Comparatively, 0.9% of Laboratory Co. of America shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Laboratory Co. of America beats Interpace Biosciences on 13 of the 17 factors compared between the two stocks.